Skip to content
← Full study record

NCT00580372 · MORE INFO

Limitations, agreements, and source contact

UARK 89-001 Phase II Study of Intensive "TOTAL THERAPY" For Untreated or Minimally Treated Patients With Multiple Myeloma · Source last updated 2016-09-20

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
organization
University of Arkansas for Medical Science
phone
501-526-2873
title
Dr. Bart Barlogie
Complete source fields
certain Agreement
pi Sponsor Employee
false
restrictive Agreement
false
point Of Contact
organization
University of Arkansas for Medical Science
phone
501-526-2873
title
Dr. Bart Barlogie

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice